Rankings
▼
Calendar
TVTX FY 2008 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TVTX
Travere Therapeutics, Inc.
$3B
FY 2008 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18,266
Net Income
-$18,266
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$18,266
Free Cash Flow
-$18,266
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$4,771
Total Liabilities
$33,859
Stockholders' Equity
$0
Cash & Equivalents
$4,771
← FY 2011
All Quarters